Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – What’s Next?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $166.6010, but opened at $153.48. Merck KGaA shares last traded at $154.00, with a volume of 50 shares traded.

Merck KGaA Price Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a 50 day simple moving average of $163.43 and a two-hundred day simple moving average of $149.49. The company has a market cap of $21.08 billion, a price-to-earnings ratio of 24.90 and a beta of 0.96.

Institutional Investors Weigh In On Merck KGaA

A number of institutional investors and hedge funds have recently made changes to their positions in MKGAF. North Star Asset Management Inc. purchased a new position in shares of Merck KGaA during the second quarter worth $1,411,000. MASTERINVEST Kapitalanlage GmbH purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at $4,896,000. Ames National Corp acquired a new position in Merck KGaA during the 2nd quarter worth about $1,009,000. Elefante Mark B purchased a new position in Merck KGaA during the 2nd quarter valued at about $617,000. Finally, Pinnacle Holdings LLC purchased a new position in Merck KGaA during the 2nd quarter valued at about $1,487,000. 0.10% of the stock is owned by hedge funds and other institutional investors.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.